$47.86
+3.46 (+7.79%)
Performance
1D
-0.02%
1W
+13.41%
1M
+72.97%
3M
-39.26%
6M
-19.29%
1Y
+75.57%
YTD
+52.42%
Open$45.36
Previous Close$44.40
Day High$48.25
Day Low$45.08
52W High$93.61
52W Low$22.31
Volume—
Avg Volume2.98M
Market Cap3.97B
P/E Ratio28.67
EPS$1.39
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$49.99
Below
SMA 200
$54.45
Below
RSI (14)
72.7
Overbought
Trend
Death Cross
Bearish
Analyst Ratings
Buy
15 analysts
Price Target
-9.8% upside
Current
$47.86
$47.86
Target
$43.17
$43.17
$30.71
$43.17 avg
$51.56
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 164.67M | 12.24M | 783.80M |
| Net Income | -71,687,671 | -102,665,771 | 150.56M |
| Profit Margin | -43.5% | -885.1% | 19.2% |
| EBITDA | -53,409,955 | -104,281,125 | 266.89M |
| Free Cash Flow | — | — | 76.52M |
| Rev Growth | +115.0% | +2.9% | +0.6% |
| Debt/Equity | 1.49 | 1.49 | 0.76 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,422.11 | +0.72% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $281.96 | -0.05% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.82 | -1.30% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.25 | +0.07% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.20 | +0.10% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $81.95 | -0.45% | 12.8 | 33.59B |